Here is the latest stock price and chart of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
JUST IN: Limited-Time Access to Full Transcript of Our Urgent Broadcast on India's Revival
Live BSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,456.35 | Open (Rs) 3,502.05 | High (Rs) 3,502.05 | Low (Rs) 3,448.35 |
% Change-1.30 | Volume 2,296 | Value (Rs) 7,968,283 | 52-Week H/L 4,970.00 / 2,540.00 |
Live NSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,455.70 | Open (Rs) 3,485.05 | High (Rs) 3,504.90 | Low (Rs) 3,450.00 |
% Change-1.41 | Volume 27,201 | Value (Rs) 94,417,678 | 52-Week H/L 4,970.00 / 2,538.00 |
Change | |||||
---|---|---|---|---|---|
1 Day -1.30% | 1 Month 8.59% | 3 Months -14.16% | 1 Year 34.55% | 5 Years (CAGR)* 24.02% | 10 Years (CAGR)* 9.86% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 30.24 | P/E Ratio (x) 114.29 | Market Cap (Rs m) 86,408.75 | P/BV (x) 34.99 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
ASTRAZENECA PHARMA last traded price was down 1.3% to Rs 3,456.4 on the BSE. On the NSE, ASTRAZENECA PHARMA last traded price was down 1.4% to Rs 3,455.7. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.9%. And the benchmark S&P BSE SENSEX was at 48,832.0 (up 0.1%).
Over the last 30 days, the ASTRAZENECA PHARMA share price is up 4.4%. And over the last one year, ASTRAZENECA PHARMA share price is up 34.4%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.
For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
This could take India to the position of 3rd largest economy.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More